Lv1
44 积分 2022-09-23 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
1个月前
已完结
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data
2个月前
已完结
Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection
3个月前
已完结
Quantifying renal lipid accumulation in obese murine models using Magnetic Resonance Imaging (MRI)
3个月前
已完结
Non-invasive characterisation of non-alcoholic fatty liver disease by MRI
3个月前
已关闭
Pathophysiologic Mapping of Chronic Liver Diseases With Longitudinal Multiparametric MRI in Animal Models
3个月前
已完结
Discovery and Tuning of RNA Editing Guides via High‐Throughput Screening and Chemical Modification
3个月前
已完结
The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
3个月前
已完结
Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3
3个月前
已完结
皖公网安备34019202002308
